BioSpace News Archive

Werewolf Therapeutics, Inc. announced the publication of an abstract for an upcoming poster presentation at IMMUNOLOGYTM 2024, the annual meeting of the American Association of Immunologists taking place May 3-7 in Chicago, Illinois.

Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, will share new data at the 20th European Association of Dermato-Oncology Congress, being held April 4-6, 2024, in Paris, France, that demonstrate the ability of its DecisionDx-Melanoma and DecisionDx-SCC tests to improve clinical-decision making through precise risk-stratification of patients with cutaneous melanoma and squamous cell carcinoma.

This event will be webcast live and a replay will be available on 3M’s Investor Relations website.

Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the first quarter 2024 following the close of market on Thursday, May 2, 2024.

CareRx Corporation (TSX: CRRX) (“CareRx” or the “Company”), Canada’s leading provider of pharmacy services to seniors living and other congregate care

Galmed Pharmaceuticals Ltd. announced that it has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission.

Biophytis SA announces the approval of all the resolutions presented by the Company and falling within the remit of the Ordinary and Extraordinary General Meeting.

Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”) today announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference and participate in one-on-one investor meetings on April 11, 2024.

Contineum Therapeutics, Inc. announced the pricing of its initial public offering of 6,875,000 shares of its Class A common stock at a price to the public of $16.00 per share.

Sirona Biochem Corp. has closed its private placement for gross proceeds of $132,500 CAD.